Role of the renin-angiotensin system in prostaglandin E2-induced hypertension.
1980; Lippincott Williams & Wilkins; Volume: 2; Issue: 4 Linguagem: Inglês
10.1161/01.hyp.2.4.529
ISSN1524-4563
AutoresGregory M. Hockel, Allen W. Cowley,
Tópico(s)Renin-Angiotensin System Studies
ResumoHomeHypertensionVol. 2, No. 4Role of the renin-angiotensin system in prostaglandin E2-induced hypertension. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBRole of the renin-angiotensin system in prostaglandin E2-induced hypertension. G M Hockel and A W CowleyJr G M HockelG M Hockel and A W CowleyJrA W CowleyJr Originally published1 Jul 1980https://doi.org/10.1161/01.HYP.2.4.529Hypertension. 1980;2:529–537 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Liu B, Wu X, Zeng R, Yin Y, Guo T, Xu Y, Zhang Y, Leng J, Ge J, Yu G, Guo J and Zhou Y (2019) Prostaglandin E 2 sequentially activates E‐prostanoid receptor‐3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature , The FASEB Journal, 10.1096/fj.201901611R, 34:2, (2568-2578), Online publication date: 1-Feb-2020. Stock J, Shinjo K, Burkhardt J, Roach M, Taniguchi K, Ishikawa T, Kim H, Flannery P, Coffman T, McNeish J and Audoly L (2001) The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure, Journal of Clinical Investigation, 10.1172/JCI6749, 107:3, (325-331), Online publication date: 1-Feb-2001. Wang J, Cheng H and Harris R (1999) Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension, Hypertension, 34:1, (96-101), Online publication date: 1-Jul-1999. Audoly L, Tilley S, Goulet J, Key M, Nguyen M, Stock J, McNeish J, Koller B and Coffman T (1999) Identification of specific EP receptors responsible for the hemodynamic effects of PGE 2 , American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.1999.277.3.H924, 277:3, (H924-H930), Online publication date: 1-Sep-1999. Tilley S, Audoly L, Hicks E, Kim H, Flannery P, Coffman T and Koller B (1999) Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor, Journal of Clinical Investigation, 10.1172/JCI6579, 103:11, (1539-1545), Online publication date: 1-Jun-1999. Cowley A, Skelton M and Merrill D (1986) Are hypertensive effects of aldosterone, angiotensin, vasopressin, and norepinephrine chronically additive?, Hypertension, 8:4, (332-343), Online publication date: 1-Apr-1986. Boudier H (1984) The interaction of antihypertensive drugs with mechanisms of blood pressure regulation Pharmacology of Antihypertensive Drugs, 10.1016/B978-0-444-90313-6.50009-5, (46-65), . HAYASHI M, FLUITA A and SATOH S (1983) DIFFERENT MODE OF ACTION BETWEEN NOREPINEPHRINE AND PHENYLEPHRINE ON PROSTAGLANDIN SYNTHESIS BY DOG RENAL INNER MEDULLARY SLICES, Japanese Journal of Pharmacology, 10.1016/S0021-5198(19)52492-1, 33:3, (563-571), . July 1980Vol 2, Issue 4 Article InformationMetrics Copyright © 1980 by American Heart Associationhttps://doi.org/10.1161/01.HYP.2.4.529PMID: 6995293 Originally publishedJuly 1, 1980 PDF download Advertisement
Referência(s)